Lung Adenocarcinoma Latest Advances

Systems Biology-Based Drug Repositioning Identifies Extracellular Matrix Module as a Therapeutic Target in Lung Squamous Cell Carcinoma.

Journal: Journal of medicinal chemistry

Published: October 17, 2025

Correction to: From lung to breast: a rare case of metastatic lung adenocarcinoma presenting as a breast lump in a male patient.

Journal: Journal of surgical case reports

Published: October 17, 2025

Integrative Transcriptomic and Metabolomic Analysis Reveals Aberrant Glycosylation as a Hallmark of Lung Adenocarcinoma.

Journal: Omics : a journal of integrative biology

Published: October 17, 2025

Prostate-specific membrane antigen expression in bone metastases of lung adenocarcinoma: implications for diagnostic and therapeutic strategies.

Journal: Polish archives of internal medicine

Published: October 16, 2025

A clinicopathological study of eight cases presenting a Biphasic structure: A distinct variant of pulmonary carcinoma.

Journal: Histology and histopathology

Published: October 15, 2025

EOAI3402143 inhibits lung adenocarcinoma progression through the NF-κB/NR4A1 pathway.

Journal: Acta biochimica et biophysica Sinica

Published: October 11, 2025

Development of an effective drug carrier for targeted therapy in lung adenocarcinoma using ROS-responsive micelles.

Journal: Journal of drug targeting

Published: October 09, 2025

DNAJA1 as a modulator of CD8+ T-cell function and prognosis in lung cancer: implications for immune regulation and therapeutic targeting.

Journal: Journal of drug targeting

Published: October 08, 2025

Corrigendum to "Tumor Necrosis Factor-α-Dependent Inflammation Upregulates High Mobility Group Box 1 To Induce Tumor Promotion and Anti-Programmed Cell Death Protein-1 Immunotherapy Resistance in Lung Adenocarcinoma" [Laboratory Investigation 105 (2025) 102164].

Journal: Laboratory investigation; a journal of technical methods and pathology

Published: October 03, 2025

[Expression of Concern] siRNA targeting of Trop2 suppresses the proliferation and invasion of lung adenocarcinoma H460 cells.

Journal: Experimental and therapeutic medicine

Published: September 29, 2025

Lung Adenocarcinoma Just Desserts: An Expanding Pie of Activating Oncogenes or a Layer Cake of Integrated Alterations.

Journal: bioRxiv : the preprint server for biology

Published: September 26, 2025

Artificial Intelligence-Based Model Exploiting Hematoxylin and Eosin Images to Predict Rare Gene Mutations in Patients With Lung Adenocarcinoma.

Journal: JCO clinical cancer informatics

Published: September 26, 2025

Filters

Systems Biology-Based Drug Repositioning Identifies Extracellular Matrix Module as a Therapeutic Target in Lung Squamous Cell Carcinoma.

Systems Biology-Based Drug Repositioning Identifies Extracellular Matrix Module as a Therapeutic Target in Lung Squamous Cell Carcinoma.

Correction to: From lung to breast: a rare case of metastatic lung adenocarcinoma presenting as a breast lump in a male patient.

Correction to: From lung to breast: a rare case of metastatic lung adenocarcinoma presenting as a breast lump in a male patient.

Integrative Transcriptomic and Metabolomic Analysis Reveals Aberrant Glycosylation as a Hallmark of Lung Adenocarcinoma.

Integrative Transcriptomic and Metabolomic Analysis Reveals Aberrant Glycosylation as a Hallmark of Lung Adenocarcinoma.

Prostate-specific membrane antigen expression in bone metastases of lung adenocarcinoma: implications for diagnostic and therapeutic strategies.

Prostate-specific membrane antigen expression in bone metastases of lung adenocarcinoma: implications for diagnostic and therapeutic strategies.

A clinicopathological study of eight cases presenting a Biphasic structure: A distinct variant of pulmonary carcinoma.

A clinicopathological study of eight cases presenting a Biphasic structure: A distinct variant of pulmonary carcinoma.

EOAI3402143 inhibits lung adenocarcinoma progression through the NF-κB/NR4A1 pathway.

EOAI3402143 inhibits lung adenocarcinoma progression through the NF-κB/NR4A1 pathway.

Development of an effective drug carrier for targeted therapy in lung adenocarcinoma using ROS-responsive micelles.

Development of an effective drug carrier for targeted therapy in lung adenocarcinoma using ROS-responsive micelles.

DNAJA1 as a modulator of CD8+ T-cell function and prognosis in lung cancer: implications for immune regulation and therapeutic targeting.

DNAJA1 as a modulator of CD8+ T-cell function and prognosis in lung cancer: implications for immune regulation and therapeutic targeting.

Corrigendum to "Tumor Necrosis Factor-α-Dependent Inflammation Upregulates High Mobility Group Box 1 To Induce Tumor Promotion and Anti-Programmed Cell Death Protein-1 Immunotherapy Resistance in Lung Adenocarcinoma" [Laboratory Investigation 105 (2025) 102164].

Corrigendum to "Tumor Necrosis Factor-α-Dependent Inflammation Upregulates High Mobility Group Box 1 To Induce Tumor Promotion and Anti-Programmed Cell Death Protein-1 Immunotherapy Resistance in Lung Adenocarcinoma" [Laboratory Investigation 105 (2025) 102164].

[Expression of Concern] siRNA targeting of Trop2 suppresses the proliferation and invasion of lung adenocarcinoma H460 cells.

[Expression of Concern] siRNA targeting of Trop2 suppresses the proliferation and invasion of lung adenocarcinoma H460 cells.

Lung Adenocarcinoma Just Desserts: An Expanding Pie of Activating Oncogenes or a Layer Cake of Integrated Alterations.

Lung Adenocarcinoma Just Desserts: An Expanding Pie of Activating Oncogenes or a Layer Cake of Integrated Alterations.

Artificial Intelligence-Based Model Exploiting Hematoxylin and Eosin Images to Predict Rare Gene Mutations in Patients With Lung Adenocarcinoma.

Artificial Intelligence-Based Model Exploiting Hematoxylin and Eosin Images to Predict Rare Gene Mutations in Patients With Lung Adenocarcinoma.